18 results on '"Kotsianidis I"'
Search Results
2. P101 - Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISK MYELODYSPLASTIC SYNDROME (HR-MDS): THE ROLE OF THE ADENOSINE DEAMINASE ACTING ON RNA 1 (ADAR1) ENZYME
3. P082 - Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: SYSTEMATIC ANALYSIS OF T LYMPHOCYTES IN MYELOID NEOPLASMS
4. P011 - Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): GENOMIC CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES
5. O05 - CURRENT CARDIOVASCULAR DISEASE (CVD) RISK PREDICTION MODELS ARE NOT APPLICABLE IN MDS PATIENTS: PRELIMINARY RESULTS OF A PROSPECTIVE OBSERVATIONAL SINGLE-CENTRE COHORT STUDY
6. Cardiovascular involvement in patients with β-thalassemia major without cardiac iron overload
7. 123 - Lenalidomide Induces Responses in Patients with MDS-DEL(5)Q Alone, or with One Additional Abnormality, Irrespective of Who Classification and Prognostic Categorization
8. 113 - Primary Resistance to Azacytidine in MDS: Preliminary Data on the Potential Role of HIF-1A Expression – the Hellenic MDS Study Group
9. 49 - Outcome of Lower-Risk Patients with Myelodysplastic Syndromes without 5Q Deletion after Failure of Erythropoiesis Stimulating Agents
10. Signal Transducer and Activator of Transcription (STAT) signaling b profile at the single cell level: Novel insights in the association of FOXP3+ T regulatory cells with recurrent spontaneous abortions before and after lymphocyte immunotherapy (LIT)
11. Long-term bone marrow cultures (LTBMC) from essential thrombocythemia (ET) patients with or without JAK2617V>F mutation
12. 283 AZACYTIDINE UPREGULATES PERFORIN EXPRESSION IN CYTOTOXIC T AND NATURAL KILLER CELLS OF RESPONDING PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)
13. P-244 Distinct epigenetic modulation of signal transducer and activator of transcription (STAT) signaling in FOXP3+ T regulatory cells of CMML-2 patients
14. 319 Response to treatment with erythropoietin in patients with MDS highly predicts low risk of evolution to AML and longer survival
15. 311 STAT signaling alterations in leukemic progenitors can predict the response of myelodysplastic syndrome (MDS) patients to azacytidine
16. 294 Prognostic significance of beta 2 microglobulin in survival and transformation to acute myelogenous leukemia in patients with myelodysplastic syndrome
17. 67 Response to ESA treatment in patients with MDS: Determination of a predictive score, from a retrospective analysis of 669 patients
18. P050 Evidence for a role of CD4+CD25high Foxp3+ regulatory T-cells in the pathogenesis of myelodysplastic syndromes (MDS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.